02.01.2015 Views

Portada Simposios - Supplements - Haematologica

Portada Simposios - Supplements - Haematologica

Portada Simposios - Supplements - Haematologica

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

XLII Reunión Nacional de la AEHH y XVI Congreso de la SETH. <strong>Simposios</strong><br />

265<br />

Table 1. Classification and distinguishing features of Congenital Dyserythropoietic Anemias (CDAs)<br />

Type Clinical features Morphology Inheritance<br />

I<br />

Anemia with neonatal<br />

appearance; jaundice,<br />

splenomegaly; rare syndactyly<br />

Common complication:<br />

hemochromatosis<br />

Anemia; jaundice; splenomagaly<br />

Hemochromatosis<br />

Gallstones<br />

Anemia mild to moderate;<br />

jaundice<br />

Gammopathy<br />

Severe or transfusion-dependent<br />

anemia with neonatal<br />

or infant appearance<br />

Megaloblastoid erythroid<br />

hyperplasia; nuclear bridges.<br />

ME: spongy-appearing nuclei<br />

and invagination of the<br />

cytoplasm in the nucleus<br />

2-4 nucleated late erythroblasts<br />

Karyorrhexis<br />

Auto-recessive<br />

Locus: 15q15.1-15.3<br />

II<br />

Auto-recessive<br />

20q11.2<br />

III<br />

Giant multinucleated<br />

erythroblasts<br />

Dominant<br />

15q22<br />

IV<br />

Marked normoblastic erythroid<br />

hyperplasia with a slight<br />

to moderate increase in the<br />

proportion of erythroblasts<br />

with very irregular or<br />

karyorrhectic nuclei.<br />

ME: Absence of precipitated<br />

protein within erythroblasts<br />

Marked normoblastic/slightly<br />

megaloblastic erythroid<br />

hyperplasia with little or no<br />

erythroid dysplasia<br />

Erythroid hyperplasia with<br />

vitamin B 12 -and<br />

folate-independent florid<br />

megaloblastic erythropoiesis<br />

Severe normoblastic erythroid<br />

hyperplasia with marked<br />

abnormalities in nuclear<br />

shape in many erythroblasts<br />

ME: Intraerythroblastic<br />

inclusions resembling<br />

precipitated -or -globin<br />

chains<br />

Recessive<br />

V<br />

Low grade anemia<br />

Jaundice with predominantly<br />

unconjugated<br />

hyperbilirubinaemia<br />

Normal or near-normal Hb with<br />

Marked macrocytosis<br />

Autosomal dominant or recessive<br />

VI<br />

Unknown<br />

VII<br />

Severe anemia with neonatal<br />

appearance and transfusion<br />

dependence<br />

Splenomegaly<br />

Normal MCV<br />

Recessive (probably)<br />

morphological abnormalities of the majority of<br />

erythroblasts in the bone marrow. Although a few<br />

reports had been published under various terms before,<br />

the first by Sansone from Genoa in 1949 2 , it<br />

was H. Heimpel that introduced this term in 1966,<br />

when he observed a pair of nonidentical 16 year old<br />

twin sisters with macrocytic anemia since early childhood,<br />

moderate splenomegaly and all laboratory<br />

findings of ineffective erythropoiesis. In the bone<br />

marrow, there was excessive erythroid hyperplasia<br />

with unusual morphological changes of almost all<br />

erythroblasts 3 .<br />

Heimpel proposed to preliminary classify these<br />

disorders into three types. These first classical types<br />

(I-III) differ in bone marrow erithroid morphology as<br />

well in the inheritance pattern (table 1).<br />

This classification since its appearance showed its<br />

limitated applicability and in fact there were some<br />

dyserythropoiesis that not fulfilled these strict diagnostic<br />

criteria causing the appearance of new groups<br />

(groups IV-VII). In the Wickramasinghe studies 4<br />

approximately one third of dyserytropoietic anemias<br />

are types other than I-III. Recently he identifies four<br />

additive groups reported in table 1. However it is noteworthy<br />

that each group may be genetically heterogeneous<br />

and that the group is proposed on the basis<br />

of the common phenotypic appearance.<br />

CDA-I<br />

The clinical picture of CDA-I was quite variable.<br />

The age at diagnosis varied from birth to early adulthood.<br />

Tamary observed the largest group of these<br />

patients (mainly of bedouin origin) and she demonstrated<br />

that the vast majority of the them with<br />

CDA type I were symptomatic during the neonatal<br />

period. Their manifestations included anemia, early<br />

jaundice, hepatosplenomegaly and cardiac manifestations.<br />

No bone abnormality was observed out of

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!